|
For Immediate Release
DIA TO HOST FIRST CHINA ANNUAL MEETING
BEIJING, CHINA—OCTOBER 14, 2009—The Drug Information Association (DIA), in collaboration with the China Center for Pharmaceutical International Exchange of the State Food and Drug Administration (SFDA), will host the First China Annual Meeting: Drug Development in a Flat World—Innovation, Regulation and Globalization from November 1-3, 2009 in Beijing, China.
Speakers from major regulatory agencies, industry, and academia will lead workshops and sessions on how drug development impacts China as the country takes on an increasingly preeminent role in the global arena. Session topics will include:
• Drug Development and Regulation in the 21st Century
• Simultaneous Global Development and Multiregional Trials
• Evolving Innovation Ecology and Innovation Cluster in China
• Transformational Bioinformatics
• Good Regulatory Practice
• Biosimilars
• Developing High-quality Clinical Study Sites
• Ethical Review of Clinical Trials
• Implementation of Global GCP Standards
• Biometrics in China
Professor Sang Guowei, Vice Chairman, Standing Committee of the National People’s Congress of PRC and Member, Chinese Academy of Engineering, China, will deliver the keynote address titled, “The Pharmaceutical Industry and Innovative Drug and R&D in China Under the Environment of Financial Crisis.”
Shao Mingli, Commissioner of the SFDA, will address the conference in the opening session. Several representatives from the SFDA, FDA, EMEA, PMDA, KFDA, and TGA, will participate in presentations and discussions.
Pre-conference workshop topics will include:
• Translating the Principles of GCP to Practicalities of Effective Site Management
• Pharmacovigilance Audit, Risk Management, and Introduction to MedDRA®
• Forum for Young Professionals: Emerging Career Opportunities in the Emerging Market
"There is no doubt that drug discovery, development, and regulation is becoming more and more globalized and China is playing an increasingly important role in this new paradigm,” says Program Co-chair Ling Su, PhD, Vice President, Clinical Research and Development, Asia Pacific, Wyeth, China. “This inaugural DIA China Annual Meeting will serve as an international and neutral forum to examine important issues in global drug development and their relevance to China.”
Click here to register.
For exhibiting opportunities, contact Ting Chen at dia@diachina.org.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
###
Contact: Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski@diahome.org
|